KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $2.32.

  • Merck's EPS (Weighted Average and Diluted) rose 8709.68% to $2.32 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.57, marking a year-over-year increase of 5870.02%. This contributed to the annual value of $6.74 for FY2024, which is 471428.57% up from last year.
  • Latest data reveals that Merck reported EPS (Weighted Average and Diluted) of $2.32 as of Q3 2025, which was up 8709.68% from $1.76 recorded in Q2 2025.
  • In the past 5 years, Merck's EPS (Weighted Average and Diluted) registered a high of $2.32 during Q3 2025, and its lowest value of -$2.35 during Q2 2023.
  • For the 5-year period, Merck's EPS (Weighted Average and Diluted) averaged around $1.25, with its median value being $1.48 (2024).
  • In the last 5 years, Merck's EPS (Weighted Average and Diluted) tumbled by 25161.29% in 2023 and then soared by 40833.33% in 2024.
  • Quarter analysis of 5 years shows Merck's EPS (Weighted Average and Diluted) stood at $1.48 in 2021, then decreased by 20.27% to $1.18 in 2022, then tumbled by 140.68% to -$0.48 in 2023, then soared by 408.33% to $1.48 in 2024, then soared by 56.76% to $2.32 in 2025.
  • Its EPS (Weighted Average and Diluted) was $2.32 in Q3 2025, compared to $1.76 in Q2 2025 and $2.01 in Q1 2025.